We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 175

Disease: Human papillomavirus (HPV)

Page 3 of 9
Efficacy, Safety, and Immunogenicity of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Women Older Than 25 Years: 4-Year Interim Follow-Up of the Phase 3, Double-Blind, Randomised Controlled VIVIANE Study

This article, published in The Lancet, discusses the results of an efficacy, safety, and immunogenicity study of the human papillomavirus (HPV) 16/18 vaccine in adult women. The results showed that in women older than 25 years, the HPV 16/18 vaccine …

Author: Skinner SR, Szarewski A, Romanowski B, et al.

Publication date: 2014

Essential Training Package for 2-dose Schedule HPV Vaccine Introduction

This web page provides links in both English and French to training materials related to key aspects of human papillomavirus vaccine introduction. It includes separate training modules for the Cervarix™ two dose vial vaccine and the Gardasil™ …

Author: World Health Organization

Publication date: 2014

Essential Training Package for HPV Vaccine Introduction for Countries Introducing Cervarix™ 2 Dose Vaccine

These eight training modules relate to key aspects of the introduction of the human papillomavirus (HPV) vaccine Cervarix™. They are intended for use by health workers during vaccine introduction training sessions and contain facilitator notes …

Author: World Health Organization

Publication date: 2013

Estimating the Costs of Cervical Cancer Screening in High-Burden Sub-Saharan African Countries

This article, published in the International Journal of Gynecology & Obstetrics, reports on a study that aimed to estimate the capital investment and recurrent costs of national cervical cancer screening and precancer treatment programs in 23 …

Author: Mvundura M, Tsu V

Publication date: 2014

Estimation of the Potential Overall Impact of Human Papillomavirus Vaccination on Cervical Cancer Cases and Deaths

This article, published in Vaccine, reports on a study that aimed to estimate the potential real-life impact of the AS04-adjuvanted HPV-16/18 vaccine on cervical cancer cases and deaths at the country level. The authors found that HPV vaccination …

Author: Van Kriekinge G, Castellsagué X, Cibula D, Demarteau N

Publication date: 2014

Evaluating HPV Vaccination Pilots: Practical Experience From PATH

From 2006 to 2011, PATH conducted human papillomavirus (HPV) vaccination demonstration projects in India, Peru, Uganda, and Vietnam to provide evidence for decision-making about public-sector introduction of HPV vaccines. This report provides …

Author: PATH

Publication date: 2012

Evidence of Support for Improved Cervical Cancer Prevention in Developing Countries

This web page contains a dossier that includes statements of support for improved cervical cancer control from governments, organizations, and individuals in Africa, Asia, Latin America, and other regions. The letters, video messages, editorials, …

Author: Cervical Cancer Action, International Union Against Cancer, PATH

Publication date: 2008

Expanding Paradigms for Cervical Cancer Screening: The Impact of the Alliance for Cervical Cancer Prevention

This report documents the accomplishments and impact of the Alliance for Cervical Cancer Prevention (ACCP). It presents the state of knowledge about alternative screening strategies prior to the establishment of the partnership, as well as …

Author: Gaffikin L, Wittet S, Sherris J

Publication date: 2013

Expanding the Evidence Base to Inform Vaccine Introduction: Program Costing and Cost-Effectiveness Analyses

This supplement to Vaccine contains 38 articles featuring country-led research to support real-time policymaking, including cost-effectiveness, program costing, and analyses of financial flows for vaccine introduction. It highlights work undertaken …

Author: Andrus JK, Walker DG, eds.

Publication date: 2015

An Extended Cost-Effectiveness Analysis of Publicly Financed HPV Vaccination to Prevent Cervical Cancer in China

This article, published in Vaccine, reports on a study to evaluate the cost-effectiveness of human papillomavirus (HPV) vaccination to prevent cervical cancer in China. The authors found that HPV is cost-effective across all income groups when the …

Author: Levin CE, Sharma M, Olson Z, et al.

Publication date: 2015

Feasibility of Delivering HPV Vaccine to Girls Aged 10 to 15 Years in Uganda

This article, published in African Health Sciences, reports on a study that explored the feasibility of two human papillomavirus (HPV) vaccine delivery strategies in Uganda—a stand-alone, school-based strategy that selected girls based on their …

Author: Mugisha E, LaMontagne DS, Katahoire AR, et al.

Publication date: 2015

The Gavi Full Country Evaluations

The Gavi Full Country Evaluations (FCE) are prospective studies that aim to understand and quantify the barriers and drivers of immunization program improvement, with an emphasis on the contribution of Gavi, the Vaccine Alliance in four countries: …

Author: PATH

Gavi HPV Programs: Application to Implementation

This article, published in Vaccines, summarizes information from approved Gavi, the Vaccine Alliance human papillomavirus (HPV) vaccine demonstration program proposals and preliminary implementation findings. It highlights experiences learned from …

Author: Hanson CM, Eckert L, Bloem P, Cernuschi T

Publication date: 2015

Global Advisory Committee on Vaccine Safety: Statement on Safety of HPV Vaccines

This report presents the findings of the Global Advisory Committee on Vaccine Safety’s review of the safety profile of human papillomavirus (HPV) vaccines. After examining pre- and post-licensure data, the Committee found no safety issues that …

Author: World Health Organization

Publication date: 2015

Global Burden of Disease

The Global Burden of Disease Study is the most comprehensive global observational epidemiological study to date. It describes mortality and morbidity from major diseases, injuries, and risk factors to health at the global, national, and regional …

Author: Global Burden of Disease Study Collaborators

Global Estimates of Human Papillomavirus Vaccination Coverage by Region and Income Level: A Pooled Analysis

This article, published in The Lancet Global Health, reports on a study that aimed to quantify worldwide cumulative coverage of publicly funded human papillomavirus (HPV) immunization programs and the potential impact on future cervical cancer cases …

Author: Bruni L, Diaz M, Barrionuevo-Rosas L, et al.

Publication date: 2016

Global Progress in HPV Vaccination

This web page illustrates global progress in human papillomavirus (HPV) vaccination with a map that shows current HPV vaccination programs. It also contains a link to a short slide show that compares HPV vaccination in 2010 and 2015.

Author: Cervical Cancer Action

Publication date: 2015

Guidelines to Assure the Quality, Safety and Efficacy of Recombinant Human Papillomavirus Virus-Like Particle Vaccines

The World Health Organization convened two meetings in Geneva in 2006 where scientific experts, regulatory professionals, and other stakeholders met to develop guidelines for prophylactic human papillomavirus (HPV) vaccines. This technical document …

Author: World Health Organization Expert Committee on Biological Standardization

Publication date: 2006

Health Systems and Immunization Financing for Human Papillomavirus Vaccine Introduction in Low-Resource Settings

This article, published in Vaccine, reports on a study that assessed health systems and immunization financing in order to offer recommendations for appropriate and effective strategies for human papillomavirus (HPV) vaccine delivery in low-resource …

Author: Biellik R, Levin C, Mugisha E, et al.

Publication date: 2009

HPV and Cervical Cancer Curriculum

This e-learning tool is intended to be used as a basis for courses, workshops, and self-learning to improve individual knowledge about human papillomavirus (HPV) and cervical cancer. It includes PowerPoint presentations with speaker notes and …

Author: Union for International Cancer Control

Page 3 of 9